UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

The New England journal of medicine, 2006-11, Vol.355 (18), p.1851-1862

2006

Volltextzugriff (PDF)

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data

Journal of clinical oncology, 2018-07, Vol.36 (19), p.1981-1990

2018

Volltextzugriff (PDF)

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

Breast cancer research and treatment, 2010-08, Vol.122 (3), p.787-794

2010

Volltextzugriff (PDF)

Conventional Adjuvant Chemotherapy Versus Single-Cycle, Autograft-Supported, High-Dose, Late-Intensification Chemotherapy in High-Risk Breast Cancer Patients: A Randomized Trial

JNCI : Journal of the National Cancer Institute, 2004-07, Vol.96 (14), p.1076-1083

2004

Volltextzugriff (PDF)

Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer

Oncology, 2005-01, Vol.69 (6), p.471-477

2005

Volltextzugriff (PDF)

Intensive adjuvant chemotherapy for breast cancer

Breast cancer (Tokyo, Japan), 1999-10, Vol.6 (4), p.386-390

Leonard, Robert C. F.

1999

Volltextzugriff (PDF)

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

Acta oncologica, 2007, Vol.46 (5), p.669-677

2007

Volltextzugriff (PDF)

Maintenance Hormone Therapy with Letrozole after First-Line Chemotherapy for Advanced Breast Cancer

Oncology, 2005-01, Vol.68 (4-6), p.364-370

2005

Volltextzugriff (PDF)

Abstract P2-12-11: Does goserelin have an effect on quality of life in women who have chemotherapy for early breast cancer? Results from the OPTION randomised trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-12-11

2020

Volltextzugriff (PDF)

Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P2-P2-16-15

2020

Volltextzugriff (PDF)

Molecular analysis of non-epithelial ovarian cancer by histologic subtype

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5570-5570

2014

Volltextzugriff (PDF)

ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2531-2531

2014

Volltextzugriff (PDF)

Miltefosine in recurrent cutaneous breast cancer

The Lancet (British edition), 1997-03, Vol.349 (9052), p.621-622

1997

Volltextzugriff (PDF)

A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2547-2547

2015

Volltextzugriff (PDF)

Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2514-2514

2015

Volltextzugriff (PDF)

The relative value of anti-Müllerian hormone to predict premature menopause in patients receiving adjuvant chemotherapy for breast cancer: Results from the OPTION trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.1094-1094

2012

Volltextzugriff (PDF)

ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2576-2576

2013

Volltextzugriff (PDF)

Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis

Cancer research (Chicago, Ill.), 1996-03, Vol.56 (5), p.950-954

1996

Volltextzugriff (PDF)

p53 mutation is a common genetic event in ovarian carcinoma

Cancer research (Chicago, Ill.), 1993-05, Vol.53 (9), p.2128-2132

1993

Volltextzugriff (PDF)

Side effects of tamoxifen are distressing and common

BMJ, 1996-12, Vol.313 (7070), p.1484-1484

1996

Volltextzugriff (PDF)

Characterization and properties of nine human ovarian adenocarcinoma cell lines

Cancer research (Chicago, Ill.), 1988-11, Vol.48 (21), p.6166-6172

1988

Volltextzugriff (PDF)

Information giving in oncology: A preliminary study of tape-recorder use

British journal of clinical psychology, 1992-09, Vol.31 (3), p.357-359

1992

Volltextzugriff (PDF)

Re: erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 1999-04, Vol.91 (8), p.728-728

1999

Volltextzugriff (PDF)

Intensive Adjuvant Chemotherapy for Breast Cancer

Breast cancer (Tokyo, Japan), 1999-10, Vol.6 (4), p.386-390

Leonard, RC

1999

Volltextzugriff (PDF)

Re: erbB-2, p53, and efficacy of adjuvant theraphy in lymph node-positive breast cancer / Response

JNCI : Journal of the National Cancer Institute, 1999-04, Vol.91 (8), p.728

1999

Volltextzugriff (PDF)

1 – 25 von 811

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(700)
Mit Volltextzugriff
(631)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(501)
Life Sciences & Biomedicine
(434)
Humans
(381)
Biological And Medical Sciences
(210)
Female
(204)
Male
(189)
Medical Sciences
(189)
Middle Aged
(114)
Adult
(99)
Animals
(98)
Surgery
(64)
Aged
(61)
Pharmacology. Drug Treatments
(54)
Oncology
(53)
General & Internal Medicine
(51)
Immunology
(46)
Medicine, General & Internal
(41)
Treatment Outcome
(41)
Physical Sciences
(39)
Fundamental And Applied Biological Sciences. Psychology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

Conventional Adjuvant Chemotherapy Versus Single-Cycle, Autograft-Supported, High-Dose, Late-Intensification Chemotherapy in High-Risk Breast Cancer Patients: A Randomized Trial

Sequential Treatment with Exemestane and Non-Steroidal Aromatase Inhibitors in Advanced Breast Cancer

Intensive adjuvant chemotherapy for breast cancer

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

Maintenance Hormone Therapy with Letrozole after First-Line Chemotherapy for Advanced Breast Cancer

Abstract P2-12-11: Does goserelin have an effect on quality of life in women who have chemotherapy for early breast cancer? Results from the OPTION randomised trial

Abstract P2-16-15: 10-year outcome for women randomized in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: An anglo-celtic cooperative oncology group study

Molecular analysis of non-epithelial ovarian cancer by histologic subtype

ProGem1: A phase I/II study of a first-in-class nucleotide, Acelarin, in patients with advanced solid tumors

Miltefosine in recurrent cutaneous breast cancer

A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancers

Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies

The relative value of anti-Müllerian hormone to predict premature menopause in patients receiving adjuvant chemotherapy for breast cancer: Results from the OPTION trial

ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors

Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis

p53 mutation is a common genetic event in ovarian carcinoma

Side effects of tamoxifen are distressing and common

Characterization and properties of nine human ovarian adenocarcinoma cell lines

Information giving in oncology: A preliminary study of tape-recorder use

Re: erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

Intensive Adjuvant Chemotherapy for Breast Cancer

Re: erbB-2, p53, and efficacy of adjuvant theraphy in lymph node-positive breast cancer / Response

Aktive Filter

Suchergebnisse filtern